How to appeal a Humana pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology

Cited policy: Humana Medicare Advantage / Commercial DME Policy on Insulin Pump + Continuous Glucose Monitor (mirrors ADA Standards of Care + ISPAD)

ADA Standards of Care peds + ISPAD: CGM standard of care for all pediatric T1D regardless of A1c; insulin pump indicated for HbA1c not at target, hypoglycemia unawareness, severe hypoglycemia history, dawn phenomenon, lifestyle/school accommodation, multiple daily injection inadequate; peds endo prescribing.

How Humana denies pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology — and how to counter it

Where Humana pushes back: 1) HbA1c 'not bad enough'; 2) MDI 'should be sufficient'; 3) Pump 'too complex for child'; 4) CGM 'finger sticks adequate'.

Counter-arguments that hold up: Cite ADA Standards of Medical Care in Diabetes — Children and Adolescents (annual update); ISPAD Clinical Practice Consensus Guidelines. Document hypoglycemia events + nocturnal hypoglycemia + hypoglycemia unawareness + school adherence challenges + family adherence + HbA1c trajectory. CGM is now standard of care regardless of A1c per ADA. Pump FDA-approved peds (Tandem t:slim X2, Medtronic 670G/770G/780G, Omnipod 5 — all peds on-label). Peds endo + diabetes educator + dietitian team.

What Humana typically denies for pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology, expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Peds congenital heart surgery
• Kawasaki workup + IVIG
• Pediatric ECMO
• Peds EoE workup + therapy
• Peds IBD biologic
• Peds asthma biologic / admission

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.